Clinical Trial Update: A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for KN046 in locally advanced or metastatic triple-negative breast cancer completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• KN046

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Triple-negative Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED